A carregar...
Should patient groups accept money from drug companies? Yes
Patient groups provide valuable support and advocacy for vulnerable people but funding the work can be difficult. Alastair Kent argues that not accepting industry money will unnecessarily limit the groups' effectiveness, but Barbara Mintzes believes that the money undermines their independence
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group Ltd.
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1865450/ https://ncbi.nlm.nih.gov/pubmed/17478845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.39185.461968.AD |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|